Table 1 Cohort characteristics of BRCA1/2 mutations carriers

From: Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

 

BRCA1

(n = 1550)

BRCA2

(n = 964)

BRCA1/2 combined

(n = 2514)

 

BC+a

BC−a

BC+a

BC−a

BC+a

BC−a

n (%)

630 (40.7)

920 (59.3)

308 (31.9)

656 (68.1)

938 (37.3)

1576 (62.7)

Data source, n (%)

  HEBON

629 (99.8)

913 (99.2)

308 (100)

639 (97.4)

937 (99.9)

1552 (98.5)

  HEBON + PGD:

      

   PGD < HEBON

1 (0.2)

2 (0.2)

0 (0.0)

5 (0.8)

1 (0.1)

7 (0.4)

   PGD > HEBON

0 (0.0)

1 (0.1)

0 (0.0)

4 (0.6)

0 (0.0)

5 (0.3)

  PGD only

0 (0.0)

4 (0.4)

0 (0.0)

8 (1.2)

0 (0.0)

12 (0.8)

Age at censoring (years) (%)

  Mean age at censoring (SD)

40.1 (8.5)

43.1 (11.6)

44.4 (8.9)

44.6 (12.0)

41.5 (8.9)

43.7 (11.8)

  <35

176 (27.9)

247 (26.9)

36 (11.7)

149 (22.7)

212 (22.6)

396 (25.1)

  35–44

276 (43.8)

259 (28.2)

132 (42.9)

190 (29.0)

408 (43.5)

449 (28.5)

  45–64

175 (27.8)

384 (41.7)

139 (45.1)

276 (42.1)

314 (33.5)

660 (41.9)

  65+

3 (0.5)

30 (3.3)

1 (0.3)

41 (6.3)

4 (0.4)

71 (4.5)

Censoring reason

  Baseline Q/PGD contact

0 (0.0)

561 (61.0)

0 (0.0)

429 (65.4)

0 (0.0)

990 (62.8)

  Breast cancer

630 (100)

0 (0.0)

308 (100)

0 (0.0)

938 (100)

0 (0.0)

  Other cancer

0 (0.0)

90 (9.8)

0 (0.0)

73 (11.1)

0 (0.0)

163 (10.3)

  BPM

0 (0.0)

269 (29.2)

0 (0.0)

154 (23.5)

0 (0.0)

423 (26.8)

Birth year (%)

  1940–1957

244 (38.7)

216 (23.5)

153 (49.7)

191 (29.1)

397 (42.3)

407 (25.8)

  1958–1968

231 (36.7)

296 (32.2)

101 (32.8)

189 (28.8)

332 (35.4)

485 (30.8)

  1969–1993

155 (24.6)

408 (44.4)

54 (17.5)

276 (42.1)

209 (22.3)

684 (43.4)

IVF (%)

  No

616 (97.8)

889 (96.6)

305 (99.0)

624 (95.1)

921 (98.2)

1513 (96.0)

  Yes

12 (1.9)

29 (3.2)

3 (1.0)

32 (4.9)

15 (1.6)

61 (3.9)

   Missing

2 (0.3)

2 (0.2)

0 (0.0)

0 (0.0)

2 (0.2)

2 (0.1)

  1. BC breast cancer, SD standard deviation, Q questionnaire, IVF in vitro fertilisation, PGD preimplantation genetic diagnosis.
  2. aDistribution of variables at the time of censoring